Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCQS Natural Resources Growth & Income Regulatory News (CYN)

Share Price Information for CQS Natural Resources Growth & Income (CYN)

Share Price is delayed by 15 minutes
Get Live Data
370.00    -4.00 (-1.06%)
Bid:
370.00
Ask:
377.00
Spread: 7.00 (1.892%)
Market Cap: £134.36m
CYN Live PriceLast checked at - London Stock Exchange

Intraday CQS Natural Resources Growth & Income Share Chart

Flash note from QuotedData

13 Jan 2025 11:34

RNS Number : 1058T
CQS Natural Resources Grwth&Inc PLC
13 January 2025
 

CQS Natural Resources Growth and Income - Flash note from QuotedData

13th January 2025

Protect your investment - get out and vote

On 18 December 2024, CQS Natural Resources Growth and Income (CYN) received a requisition notice from a nominee of Saba Capital Management LP (Saba) requiring it to convene a general meeting for shareholders to consider resolutions proposed by Saba to remove the existing completely-independent board of non-executive directors and replace it with two directors of Saba's choosing.

On 7 January 2025, CYN's board issued a comprehensive rebuttal of Saba's proposals when it published a circular (a formal document sent to shareholders) in relation to the requisitioned meeting - it describes Saba's proposals as "self-interested and misleading." The board's position is very clear - it is unanimous in recommending shareholders vote against Saba's resolutions.

From the outset, we have cautioned shareholders against giving full control of the trust to one dominant shareholder that would be free to act entirely in its own interests. Saba has made clear its intention to get itself appointed as manager and merge the seven targets into one large vehicle with a mandate to attack other investment companies. The FCA's (Financial Conduct Authority) Listing Rules make it clear that the board of directors of an investment company must be able to act independently of any investment manager. We are not comfortable that Saba's proposals meet this requirement.

With so much at stake, we thought we should take a deeper look at Saba's proposals and CYN's board's response to these, to see what the merits are. Our conclusion is that Saba's plans for CYN are so poor for all shareholders other than itself that its proposals deserve to be voted down comprehensively. We urge all shareholders: protect your investment and get out and vote.

Full Research:

https://quoteddata.com/research/cqs-natural-resources-growth-and-income-protect-your-investment-get-out-and-vote-qd/

This research is also available free on our website www.quoteddata.com where you will also find news, performance data and factsheets on every London listed Investment Company. QuotedData writes and distributes research on a number of quoted companies, facilitates meetings between those companies and existing and potential investors and assists in raising additional capital where required.

NB: Marten & Co was paid to produce this note CQS Natural Resources Growth and Income Plc, and it is for information purposes only. It is not intended to encourage the reader to deal in the security or securities mentioned in this report. Please read the important information at the back of this note. QuotedData is a trading name of Marten & Co Limited which is authorised and regulated by the Financial Conduct Authority. Marten & Co is not permitted to provide investment advice to individual investors categorised as Retail Clients under the rules of the Financial Conduct Authority.

QUOTEDDATA50 Gresham Street | London EC2V 7AYTel: +44 (0) 20 3691 9430

www.quoteddata.com | research@quoteddata.com | www.martenandco.com

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAUOOARVAUAAAR
Date   Source Headline
1st Apr 20261:52 pmRNSNet Asset Value(s)
1st Apr 20261:35 pmRNSTotal Voting Rights
31st Mar 202611:37 amRNSNet Asset Value(s)
30th Mar 202612:11 pmRNSNet Asset Value(s)
27th Mar 20261:08 pmRNSNet Asset Value(s)
26th Mar 20265:26 pmRNSTransaction in Own Shares
26th Mar 202612:54 pmRNSNet Asset Value(s)
25th Mar 20262:19 pmRNSNet Asset Value(s)
25th Mar 20267:00 amRNSHalf-Year Financial Report
24th Mar 20265:55 pmRNSTransaction in Own Shares
24th Mar 20263:15 pmRNSMonthly Factsheet as at 28 February 2026
24th Mar 202612:06 pmRNSNet Asset Value(s)
23rd Mar 20261:02 pmRNSNet Asset Value(s)
23rd Mar 20267:00 amRNSService of Protective Notice
20th Mar 20265:48 pmRNSTransaction in Own Shares
20th Mar 202612:54 pmRNSNet Asset Value(s)
19th Mar 20265:11 pmRNSTransaction in Own Shares
19th Mar 202612:02 pmRNSNet Asset Value(s)
18th Mar 20265:37 pmRNSTransaction in Own Shares
18th Mar 20261:17 pmRNSNet Asset Value(s)
17th Mar 202612:34 pmRNSNet Asset Value(s)
16th Mar 202612:28 pmRNSNet Asset Value(s)
11th Mar 20267:00 amRNSUpdate on Portfolio Position/Rebalancing
10th Mar 202612:04 pmRNSNet Asset Value(s)
9th Mar 20265:10 pmRNSTransaction in Own Shares
9th Mar 20261:04 pmRNSNet Asset Value(s)
9th Mar 20267:00 amRNSResignation of portfolio managers
6th Mar 20265:15 pmRNSTransaction in Own Shares
6th Mar 20261:17 pmRNSNet Asset Value(s)
5th Mar 202611:58 amRNSNet Asset Value(s)
4th Mar 20261:05 pmRNSNet Asset Value(s)
3rd Mar 202612:45 pmRNSNet Asset Value(s)
2nd Mar 20261:10 pmRNSNet Asset Value(s)
2nd Mar 20269:33 amRNSTotal Voting Rights
27th Feb 20263:59 pmRNSNet Asset Value(s)
27th Feb 202612:33 pmRNSDirector/PDMR Shareholding
26th Feb 20261:05 pmRNSNet Asset Value(s)
25th Feb 20262:19 pmRNSNet Asset Value(s)
24th Feb 20265:02 pmRNSSale of Shares from Treasury
24th Feb 20261:38 pmRNSNet Asset Value(s)
23rd Feb 20261:34 pmRNSNet Asset Value(s)
20th Feb 20262:57 pmRNSNet Asset Value(s)
20th Feb 20269:58 amRNSMonthly Factsheet as at 31 January 2026
20th Feb 20267:00 amRNSCompliance with Market Abuse Regulation
19th Feb 202612:11 pmRNSNet Asset Value(s)
18th Feb 20261:00 pmRNSNet Asset Value(s)
17th Feb 202611:31 amRNSNet Asset Value(s)
16th Feb 202612:40 pmRNSNet Asset Value(s)
13th Feb 20263:39 pmRNSNet Asset Value(s)
12th Feb 20265:48 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.